Journal
VETERINARY PARASITOLOGY
Volume 190, Issue 1-2, Pages 136-142Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.vetpar.2012.05.027
Keywords
Caenorhabditis elegans; Onchocerca ochengi; Anogeissus leiocarpus; Levamisole; Albendazole; Ivermectin
Categories
Funding
- Alexander von Humboldt Foundation (AvH)
- Deutsche Forschungsgemeinschaft (DFG) [LI 793/5-1]
Ask authors/readers for more resources
The ethanolic extract of Anogeissus leiocarpus was assessed for the in vitro anthelmintic activity by using the cattle parasite nematode Onchocerca ochengi as well as levamisole-, ivermectin- and albendazole-resistant mutant strains of the free-living nematode Caenorhabditis elegans, a model organism for research on nematode parasites. Worms were incubated in the presence of different concentrations of the plant extract and effects on survival were monitored after each 12 h to 96 h. The A. leiocarpus extract affected O. ochengi microfilaria, adults, and C. elegans wild-type worms with LC50 values of 0.06 mg/ml, 0.09 mg/ml after 24 h and 0.44 mg/ml after 48 h, respectively. Remarkably, the efficacy of the plant extract was not significantly altered in the ivermectin- and levamisole-resistant C elegans mutant strains lev-1(e211), gic-2(ok1047), lev-9(x16) and avr-14(ad1302), avr-15(ad1051), glc-1(pk54). The albendazole resistant strain ben-1(e 1880)exhibited a moderate increase of the LC50 value to 1.5 mg/m1 after 48 h. These results are in good accordance with the use of A. leiocarpus extract against nematode infections by traditional healers, herdsmen and pastoralists. Moreover, the data indicate that the plant extract could be used to treat nematode infections even in cases of drug resistance towards established anthelmintic drugs. (C) 2012 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available